Overview
Background
Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)
Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.
Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.
Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours), University of Sydney
- Doctor of Philosophy, University of Sydney
Research interests
-
Clinical pharmacokinetics and pharmacodynamics
Many projects being undertaken to define better dosing options to give improved patient outcomes - eg. in people who have received organ transplants (tacrolimus, mycophenolate, sirolimus) or who need other immunosuppressants (eg. leflunomide in people with rheumatoid arthritis).
-
Quality use of Medicines
Numerous projects designed to improve how medicines are used - particular interests in health care teams, including consumers; rural health; medication use and misuse and international comparisons of prescription medication use
Works
Search Professor Sue Tett’s works on UQ eSpace
2006
Conference Publication
Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib
Barozzi, N. and Tett, S. E. (2006). Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib. The National Institute of Clinical Studies Using Evidence: Using, Melbourne, 19-20 October 2006. Melbourne: National Institute of Clinical Studies.
2006
Conference Publication
Spin-offs and bonanzas from Queensland participating in CAPTION
Pulver, L., Coombes, J., Petrie, A. F. and Tett, S. E. (2006). Spin-offs and bonanzas from Queensland participating in CAPTION. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited.
2006
Conference Publication
Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION project
Maxwell, D. J., Kaye, K. I., MacIntosh, K. A., Robertson, M. B., Stanton, L. A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L., Tett, S. E., Wai, A. and Mackson, J. (2006). Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION project. Australian Society for Antimicrobials 7th Annual Scientific Meeting, Sydney / Crowne Plaza, Coogee Beach, 23-25 February 2006. Sydney: Australian Society for Antimicrobials.
2006
Conference Publication
How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?
Barozzi, N. and Tett, S. E. (2006). How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited.
2006
Journal Article
A Bayesian approach for population pharmacokinetic modelling of sirolimus
Dansirikul, Chantaratsamon, Morris, Raymond G., Tett, Susan E. and Duffull, Stephen B. (2006). A Bayesian approach for population pharmacokinetic modelling of sirolimus. British Journal of Clinical Pharmacology, 62 (4), 420-434. doi: 10.1111/j.1365-2125.2005.02533.x
2006
Conference Publication
Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban Queensland
Coulson, F. R. and Tett, S. E. (2006). Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban Queensland. Quality use of medicines: Balancing beliefs, benefits and harms, National Convention Centre, Canberrra, 7-9 June 2006. Brisbane: National Prescribing Service.
2005
Journal Article
Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia
Kirkpatrick, Carl M. J., Roughead, Elizabeth E., Monteith, Gregory R. and Tett, Susan E. (2005). Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia. BMC Health Services Research, 5 (1) 75, 75.1-75.7. doi: 10.1186/1472-6963-5-75
2005
Journal Article
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation
Staatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4
2005
Journal Article
Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia
Cooke, C., Nissen, L. M., Sketris, I. S. and Tett, S. E. (2005). Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia. Clinical Therapeutics, 27 (4), 497-508. doi: 10.1016/j.clinthera.2005.04.009
2005
Journal Article
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
Staatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001
2005
Conference Publication
Consumers on the map: Australia's QUM map
Tett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia.
2005
Conference Publication
How much, how often, how long?
Tett, S. E. (2005). How much, how often, how long?. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
2005
Conference Publication
Drug utilisation review across jurisdictions: A reality or still a distant dream?
Pulver, L. and Tett, S.E. (2005). Drug utilisation review across jurisdictions: A reality or still a distant dream?. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia.
2005
Journal Article
Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients
Dansirikul, C., Duffull, S. B., Morris, R. G. and Tett, S. E. (2005). Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. British Journal of Clinical Pharmacology, 60 (5), 560-565. doi: 10.1111/j.1365-2125.2005.02473.x
2005
Journal Article
Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis
Chan, V., Charles, B. G. and Tett, S. E. (2005). Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. British Journal of Clinical Pharmacology, 60 (3), 257-264. doi: 10.1111/j.1365-2125.2005.02415.x
2005
Conference Publication
Directions for pharmacy as we move forward
Tett, S. E. (2005). Directions for pharmacy as we move forward. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia.
2005
Journal Article
Empiric management of community-acquired pneumonia in Australian emergency departments
Maxwell, D. J., McIntosh, K. A., Pulver, L. K., Easton, K. L., CAPTION Study Grp and Tett, S. E. (2005). Empiric management of community-acquired pneumonia in Australian emergency departments. Medical Journal of Australia, 183 (10), 520-524. doi: 10.5694/j.1326-5377.2005.tb07153.x
2005
Other Outputs
Rural community pharmacists integrating care for people with complex health needs
Nissen, L. M. and Tett, S. E. (2005). Rural community pharmacists integrating care for people with complex health needs. Brisbane: Pharmacy Guild of Australia.
2005
Journal Article
Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period
Kiberd, B., Puthenparumpil, J. J., Fraser, A., Tett, S. E. and Lawen, J. (2005). Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. Transplantation Proceedings, 37 (5), 2320-2323. doi: 10.1016/j.transproceed.2005.03.059
2005
Conference Publication
Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol
Barozzi, N. and Tett, S.E. (2005). Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Funding
Past funding
Supervision
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Towards optimal dosing of new immunosuppressant drugs in solid organ transplants
Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered
-
International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage
International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems
-
Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and
Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc
-
Drug usage evaluation across different jurisdictions
Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences
-
Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug
Supervision history
Completed supervision
-
2009
Doctor Philosophy
Geographical differences, national and international, in the utilization of the benzodiazepine and antidepressant groups of medicines
Principal Advisor
Other advisors: Emeritus Professor Wayne Hall
-
2007
Doctor Philosophy
CONVENTIONAL MEDICINE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - CONCORDANCE AND PERSPECTIVES OF CONSUMERS, HEALTH PROFESSIONALS AND CAM PRACTITIONERS
Principal Advisor
-
2005
Doctor Philosophy
Use of leflunomide in rheumatoid arthritis
Principal Advisor
-
2004
Doctor Philosophy
Pharmacokinetic studies with sirolimus and tacrolimus
Principal Advisor
-
2002
Doctor Philosophy
POPULATION PHARMACOKINETICS AND PHARMOCODYNAMICS OF THE NEW IMMUNOSUPRESSANT DRUGS
Principal Advisor
-
2002
Doctor Philosophy
QUALITY USE OF MEDICINES: FROM DUE TO RURAL COMMUNITY PHARMACY PRACTICE
Principal Advisor
Other advisors: Emeritus Professor Maree Smith
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Associate Advisor
Other advisors: Dr Christine Staatz
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Associate Advisor
Other advisors: Dr Christine Staatz
-
2009
Doctor Philosophy
Prescription medicine samples and therapy initiation. Developing a best practice system with community pharmacists in Australia
Associate Advisor
Other advisors: Professor Lisa Nissen
-
2007
Doctor Philosophy
Optimising the assesssment of renal function and determining the renal elimination of drugs using various methodologies
Associate Advisor
Media
Enquiries
Contact Emeritus Professor Sue Tett directly for media enquiries about:
- Clinical pharmacokinetics
- Clinical pharmacy
- Medicine - quality use of
- Pharmacokinetics
- Pharmacy - clinical
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: